WILLIAM ALLDREDGE: Open Payments
NPI 1801904636 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 80 payments from 23 companies in 2025. Trend: 2023 $1,689 · 2024 $1,539 · 2025 $1,498
Food & beverage: $1,498
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $187 |
| AstraZeneca Pharmaceuticals LP | 9 | $177 |
| Indivior Inc. | 4 | $129 |
| Dexcom, Inc. | 6 | $127 |
| Lilly USA, LLC | 10 | $124 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| PFIZER INC. | 6 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $81 |
| Exact Sciences Corporation | 4 | $63 |
| ABBVIE INC. | 3 | $62 |
Products named: REXULTI, SUBLOCADE, Dexcom G6 Transmitter, FARXIGA, MOUNJARO, Ozempic, Wegovy, Kerendia.
Industry payments across AL — which companies pay providers there.
